| Name | Title | Contact Details |
|---|
Impact Cryotherapy is the national leader in designing and manufacturing whole body cryotherapy systems. The company`s state-of-the-art cryosaunas are sleek, attractive single-person chambers that are engineered and manufactured in the United States in an ISO 9001 certified facility. Impact Cryotherapy is redefining the age-old technique of cryotherapy with advanced technology and aesthetics to deliver unmatched efficiency, comfort and reliability.
BeVigour is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sunrise Dental Lab is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.